MarketScale Company
Request a demo
Subscribe
Services
Subscribe
Tuesday, June 13, 2023
Go Back

Innovative products and solutions for the life science industry's critical manufacturing environments

Welcome to Benchmark Products, the leading supplier of innovative solutions and products for life science manufacturers. With ISO 9001:2015 certification and cutting-edge ISO Class 7 Cleanroom facilities, we ensure exceptional quality. Over 500 customers trust us for custom kitting, fluid handling assemblies, product irradiation, and sterile quality assurance.

Benchmark Products

Healthcare
Podcasts
Podcasts
Sciences

How Cell and Gene Manufacturers Can Scale to Meet Demand

December 21, 2022
biomanufacturing
CDT
cell therapy
gene therapy
+more

Between 2022 and 2030, the cell and gene therapy sector is expected to experience a compound annual growth rate (CAGR) of 39.42 percent, BioSpace said of a recent Vision Research Report.

This is quite a large anticipated growth; how will startups and current manufacturing companies work to meet this growing demand?

On today’s episode of Exceeding Your Benchmark, Host Sumit Verma, Senior Vice President, Global Strategic Manufacturing at Iovance Biotherapeutics, addresses cell and gene therapy industry trends and challenges and what manufacturers can do to promote growth in the sector.

Verma also discussed…

  1. The greatest challenges biopharma startups face
  2. How established CGT manufacturers are preparing to meet an increased demand
  3. What place automation has in advanced cell manufacturing

Verma believes there are three key areas manufacturers need to target to help supply meet increasing demand. “I think most players are focusing on three big things: one is around scalability, the second is around supply chain, making sure we have all the components, and last is about talent. Verma said of the talent piece, “There aren’t many people who have advanced programs for therapeutic manufacturing today…there are a lot of synergies and the big pharma have done a great job establishing developing programs that are very supportive of their large plants and their scalable efforts and we’ve seen the need to do that in cell and gene therapy.

Recent Episodes

retail health clinic
View episode

The Retail Health Clinic Market is Expected to Double in a Few Years. Customer Experience Must Be a Priority.

  Amid hospitals experiencing workforce shortages, the retail health clinic is gaining popularity for their ability to provide quality care to millions of patients. In fact, the retail clinic market, which stood at $2.05 billion last year, is expected to reach $4.22 billion by the year 2029. But as companies like Amazon enter the healthcare industry, […]

health equity
View episode

Achieving Health Equity in Healthcare Requires Investment, Data, and Better Educational Tools

  Achieving health equity has been a long-term challenge for the healthcare industry and a topic that has received more national and global attention since the COVID-19 pandemic. Marginalized communities in particular face deep disparities when trying to access healthcare and in their health outcomes. According to the Harvard Business Review, when compared to their […]

electronic health records
View episode

With Patients Accessing Their Own Electronic Health Records, How Can Care Orgs Handle Patient Data Safely & Securely?

  Last year, the 21st Century Cures Act changed how patients could access their health data. The new rule, aimed to prevent information blocking of all electronic health information (EHI), gave patients the power to use, access, and share all of their health information. By empowering patients to access their own electronic health records and […]